MegriƱo, Novyhl Mae B.
HRN: 24-33-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
METRONIDAZOLE 500MG (TAB)
07/20/2026
07/26/2026
PO
500 Mg
TID
Thickly MSAF
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes